Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if the HemCon Dental Dressing is effective in stopping bleeding during dental surgeries in patients taking anticoagulant medications.


Clinical Trial Description

As the HemCon® Dental Dressing has been FDA cleared for use as a physical barrier for temporary protection of oral mucosal tissue and to provide pain relief, the proposed study will further investigate the safety and efficacy of hemostasis of the dressing for use in dental surgical procedures that do not require primary closure (suturing) such as tooth extractions. This protocol will specifically research the safety and efficacy of hemostasis within a population of subjects taking anticoagulant medications. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00707564
Study type Interventional
Source HemCon Medical Technologies, Inc
Contact
Status Withdrawn
Phase N/A
Start date July 2008
Completion date January 2009

See also
  Status Clinical Trial Phase
Completed NCT00639860 - Clinical and Histological Evaluation of OSSIX-Plus Resorbable Collagen Membranes for Alveolar Ridge Preservation Following Exodontia Phase 1/Phase 2
Completed NCT01139671 - Comparison of Sufentanil and Remifentanil Infusion During General Anaesthesia for Removal of Wisdom Teeth in Ambulatory Surgery Phase 4
Completed NCT00707486 - A Randomized, Self Controlled Clinical Study of Hemostatic Efficacy of the HemCon Dental Dressing Phase 3